Loading
Hinge Health, Inc. Stock: price and insider trades · United States
US·Mcap US$8.5B
Hinge Health, Inc.: what insiders have been doing
Hinge Health, Inc. is a listed company. Its directors and officers file their transactions with SEC (Form 4). Between 18 October 2025 and 18 October 2026, 24 insiders published 241 filings.
There is no open-market purchase to report; the filings show 134 sales worth €120.1M by 7 insiders. No amount is published for 65 filings, which the totals therefore leave out. One trade stands out by size: a sale of €9.6M from Insight Holdings Group, LLC, disclosed on 9 July 2026, or 0.15% of market capitalisation.
The median gap between a trade and its publication by SEC (Form 4) is 1 day. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives.
Compared with its exchange (5,808 companies, median 19 filings), a count of 241 filings is above the norm. Our records for Hinge Health, Inc. go back to 2025, with no purchases and 138 sales on the open market in total. In its latest annual report filed with the SEC (10-K, fiscal year ended 31 December 2025), the company reported revenue of 587.9 m USD and net income of -528.3 m USD.
Elsewhere in the same market, our signals recently picked up insider purchases at GameStop Corp. and Heico Corp. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Insider Decl.
255
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
€291M
138 ops. · all time
Who traded when
BuySaleInsight Holdings Group, LLC65 sales
Gabriel M.I. Mecklenburg18 sales
James Budge18 sales
Robinson Elliott13 sales
Daniel Antonio Perez11 sales
James Pursley7 sales
+4 other insiders
Analyst consensus: bullish or bearish?
Analysts rate Hinge Health, Inc. Buy (bullish), based on 16 analysts. Average price target: US$111.19.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 13,457 of 24,161 companies
48.2
score / 100
Value35
Quality62
FCF yld2.1%
Earn yld-6.6%
EV/EBITDA·
ROE30%
Gross mgn80%
Net mgn-90%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
US$105.00
Analyst consensus
16 analystsBuy
US$90.00Target US$111.19(+6%)US$140.00
Income statement
RevenueUS$587.9M
Gross profitUS$468.2M80% margin
EBITDA-US$541.2M-92% margin
Net income-US$528.3M15.1% margin
Valuation
PER (trailing)34.7x
PER (forward)34.3x
P/Book24.5x
Balance sheet & cash
Market capUS$8.5B
Total debtUS$8M
Free Cash FlowUS$165.4M
Debt / Equity2%
Profitability & ownership
ROE30.4%
ROA7.7%
% insiders4.7%
% institutions95.8%
Last declaration on 14 October 2026
Declarations255 total
614,262 shares@ US$105.00Class ASEC144:0001974078-26-000379
749,091 shares@ US$105.00Class ASEC144:0001974078-26-000380
118,822 shares@ US$105.00Class ASEC144:0001974078-26-000381
17,825 shares@ US$105.00Class ASEC144:0001974078-26-000382
47,720 shares@ US$102.900.058% mcap50.1% of flowCommonSEC144:0001950047-26-010158
200,000 shares@ US$102.900.24% mcap35.0% of flowCommonSEC144:0001950047-26-010159
200,000 shares0Class A Common StockSEC:0002062781-26-000026:0
2,100 shares@ US$101.52720.0025% mcap1.4% of flowClass A Common StockSEC:0001338176-26-000038:0
21,702 shares@ US$102.53810.026% mcap14.4% of flowClass A Common StockSEC:0001338176-26-000038:1
14,498 shares@ US$103.480.018% mcap9.7% of flowClass A Common StockSEC:0001338176-26-000038:2
9,420 shares@ US$104.3350.012% mcap6.4% of flowClass A Common StockSEC:0001338176-26-000038:3
8,642 shares@ US$101.53080.010% mcap1.5% of flowClass A Common StockSEC:0002062781-26-000026:1
91,502 shares@ US$102.53230.11% mcap15.9% of flowClass A Common StockSEC:0002062781-26-000026:2
59,988 shares@ US$103.47550.073% mcap10.5% of flowClass A Common StockSEC:0002062781-26-000026:3
39,868 shares@ US$104.33790.049% mcap7.1% of flowClass A Common StockSEC:0002062781-26-000026:4
4,100 shares@ US$100.19780.0052% mcap0.5% of flowClass A Common StockSEC:0002063236-26-000015:1
4,100 shares0Class A Common StockSEC:0002063236-26-000015:0
4,100 shares@ US$98.350.0051% mcap4.4% of flowCommonSEC144:0001950047-26-010085
175 shares@ US$92.5620.0002% mcap46.4% of flowClass A Common StockSEC:0001735436-26-000010:0
831 shares@ US$97.240.0011% mcap1.4% of flowClass A Common StockSEC:0001783108-26-000034:0
4,614 shares@ US$97.240.0058% mcap4.2% of flowClass A Common StockSEC:0001338176-26-000036:0
399,338 shares@ US$98.000.51% mcap21.5% of flowClass ASEC144:0001974078-26-000369
486,991 shares@ US$98.000.62% mcap21.5% of flowClass ASEC144:0001974078-26-000370
77,248 shares@ US$98.000.098% mcap21.5% of flowClass ASEC144:0001974078-26-000371
11,587 shares@ US$98.000.015% mcap21.5% of flowClass ASEC144:0001974078-26-000372
25 of 255 declarations
About Hinge Health, Inc.
Hinge Health, Inc. is a digital health company that provides solutions for musculoskeletal pain management. It leverages advanced technologies to improve patient outcomes and reduce healthcare costs.
Recent ranked signals on the same market
Purchases our model currently ranks for the recommendations list.
All recommendations
